dr. Patrik Olof Dahlén

Biography

 Dr. Patrik Olof Dahlén, Ph.D. is an Independent Consultant for the life science, medtech and healthcare sectors. Dr. Dahlén served as the Chief Executive Officer of Immunodiagnostic Systems Holdings Plc since July 2, 2012 until November 24, 2014. Dr. Dahlén served as the Chief Executive Officer of Neurosearch A/S from September 15, 2010 to July 1, 2012. He has 25 years of experience working in the biotech industry, including Chief Executive Officer at Chempaq A/S and various senior management positions at EG&G Reticon Inc. He served as the Chief Executive Officer at IDS Ltd. He served as President and Chief Executive Officer of Dako A/s from 2005 to January 19, 2009. From 2001 to 2005, Dr. Dahlén served as the Chief Executive Officer of Fisher BioImage ApS. From 1999 to 2001, he served as the President of PerkinElmer Life Sciences, Inc. and Senior Vice President of PerkinElmer, Inc. From 1999 to 1999, he served as the General Manager of EG&G Reticon, Inc. He served as a Vice President at PerkinElmer Inc. He served as General Manager of Wallac Isolab, Inc. from 1998 to 1999, Director of Diagnostics Division of EG&G Wallac, Inc. from 1995 to 1999, Division Head for Diagnostics Systems Division, EG&G Wallac OY from 1994 to 1995, Product Line Manager for Screening Products (Diagnostics Systems Division) of Wallac OY from 1992 to 1994, Senior Researcher of Wallac OY from 1990 to 1992, Project Leader for DNA Probes of Phage

Research Interest

 Pharmacia Genetic Engineering, Inc. from 1988 to 1990 and Junior to Senior Researcher and Project Leader of DNA Probe Group, Wallac OY from 1984 to 1988. He spent the first 16 years of his career in life science and diagnostics with PerkinElmer. He has been the Chairman for the Board of Proxeon A/S since June 2005, Advalight ApS since August 19, 2013 and Cantion A/S since June 2005. He serves as the Chairman of OLink Biosciences. He serves as the Chairman of Sophion and QuantiBact A/S. He serves as the Chairman of the Board of Denator AB, Anapa Biotech A/S and VisioPharm A/S. He serves as the Chairman at Visiopharm A/S. He served as Chairman of the Board at Olink AB. He served as Deputy Chairman of DiaGenic ASA (also known as: NEL ASA). He has been a Director of LEO Pharma A/S since April 2015 and serves as its Vice Chairman. Dr. Dahlén serves as a Director of IDS Diagnostics, Fisher BioImage ApS and Non-Executive Director at Immunodiagnostic Systems Limited. He is Board member of Immudex A/S. He served as Director of Immunovia AB (publ) until December 9, 2016. He served as a Director of Immunodiagnostic Systems Holdings Plc since December 11, 2009 until January 04, 2015. He served as Director of Contura International A/S. He served as a Director of Dako A/s from 2004 to January 19, 2009. He is author of more than 20 peer reviewed articles. Dr. Dahlén holds a Ph.D. in Biochemistry from University of Turku in 1991 and M.Sc. in Biochemistry from Åbo Akademi University, Turku in 1985.